MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA; Represents the second EMA approval of an MVA-BN-based vaccine ...

Mpox vaccines have been administered in Africa for the first time, with several hundred high-risk individuals vaccinated in ...

One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is moderately effective against mpox infection in ...

Mpox ( formerly known as monkeypox) is a viral infection that can be prevented with just a single dose of an existing vaccine ...

Lessons learned from the COVID pandemic have left the world in a much better position to tackle the current mpox epidemic ...

(RTTNews) - Bavarian Nordic A/S (BAVA) Thursday said that the European Commission has adopted the Committee for Medicinal Products for Human Use (CHMP) recommendation for the approval of a type II ...

The rate of mpox infection in the vaccinated group was 0.09 for every 1,000 person-days as compared to 0.20 in the ...

In an emulated target trial, a single dose of modified vaccinia Ankara-Bavarian Nordic vaccine was moderately effective in ...

On September 13, 2024, the World Health Organization (WHO) announced that it added the first vaccine against monkeypox (mpox) to its ...

The World Health Organization (WHO) has authorized the MVA-BN vaccine as the first vaccine against mpox to be added to its ...

A single dose of a smallpox vaccine seems to lower the risk of catching mpox by around 60 per cent, and two doses would ...

"This study reinforces the benefit in vaccinating against mpox with MVA-BN and reaffirms that a single dose provides at least ...